Relative risk reduction¶
In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group.
Core Idea¶
Relative risk reduction is treated here as the recurring clinical epidemiology identity summarized by this source-grounded definition: In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group. In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group.
Scope of Application¶
-
Documented setting. If the risk of an adverse event is increased by the exposure rather than decreased, the term relative risk increase (RRI) is used, and it is computed as (Ie - Iu)/Iu .
-
Documented setting. If the direction of risk change is not assumed, the term relative effect is used, and it is computed in the same way as relative risk increase.
-
Documented setting. In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group.
-
Documented setting. It is computed as (Iu - Ie) / Iu , where Ie is the incidence in the exposed group, and Iu is the incidence in the unexposed group.
-
Documented setting. If the risk of an adverse event is increased by the exposure rather than decreased, the term relative risk increase (RRI) is used, and it is computed as (Ie - Iu)/Iu .
Clarity¶
A clear use of Relative risk reduction names the carrier, the operative relation, and the conditions under which the source treats the identity as present. The minimal definition is In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group.
Manages Complexity¶
Relative risk reduction compresses multiple clinical epidemiology details into a stable diagnostic relation. The source shows both the central mechanism—it is computed as (Iu - Ie) / Iu , where Ie is the incidence in the exposed group, and Iu is the incidence in the unexposed group.—and the practical consequence—it is computed as (Iu - Ie) / Iu , where Ie is the incidence in the exposed group, and Iu is the incidence.
Abstract Reasoning¶
- Type the carrier. Identify the clinical epidemiology entities to which the claim applies.
- State the relation. Use the source-grounded identity: In epidemiology, the relative risk reduction (RRR) or efficacy is the relative decrease in the risk of an adverse event in the exposed group compared to an unexposed group.
- Check operation and conditions. If the direction of risk change is not assumed, the term relative effect is used, and it is computed in the same way as relative risk increase.
- Demand recognition evidence.
Knowledge Transfer¶
Within the home domain. Knowledge about Relative risk reduction transfers literally when a new case preserves the same carrier type, relation, and recognition test. If the risk of an adverse event is increased by the exposure rather than decreased, the term relative risk increase (RRI) is used, and it is computed as (Ie - Iu)/Iu . If the direction of risk change is not assumed, the term relative effect is used, and it is computed in the same way as relative.
Relationships to Other Abstractions¶
Current abstraction Relative risk reduction Domain-specific
Parents (1) — more general patterns this builds on
-
Relative risk reduction is a kind of Relative Change Prime
Relative risk reduction computes the reduction from a comparison risk relative to the declared reference risk, preserving proportional rather than absolute change.
Hierarchy path (1) — routes to 1 parentless root
- Relative risk reduction → Relative Change → Ratio → Comparison → Self Checking
Neighborhood in Abstraction Space¶
Relative risk reduction sits in a sparse region of the domain-specific corpus (81st percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Clinical Trial & Research Methodology (20 abstractions)
Nearest neighbors
- In silico clinical trials — 0.83
- Table 2 fallacy — 0.82
- Attack rate — 0.82
- Value at risk — 0.82
- Surrogate Endpoint — 0.82
Computed from structural-signature embeddings · 2026-10-08